Celon Pharma S.A., a prominent Warsaw Stock Exchange-listed pharmaceutical company, is a powerhouse of European drug research and manufacturing. Driven by a dedicated team of over 160 scientists, the company manages an advanced pipeline spanning oncology, neurology, diabetes, and respiratory therapies, while holding a position as a global leader in dry powder inhaler technology.
To scale its specialised manufacturing capabilities, Celon Pharma signed a 20-year lease at CTPark Žilina Airport, launching a ca. €16 million investment in a purpose-built, GMP-compliant facility dedicated to filling injectable medicines.
Choosing Žilina offers critical regional advantages that enhance high-tech pharmaceutical logistics. Strategically positioned in Slovakia, the site sits just 40 km from the Czech border and 50 km from the Polish border, streamlining cross-border supply chains. Immediate access to the D1/E50 motorway corridor ensures rapid, temperature-controlled distribution across Central Europe. Furthermore, proximity to Žilina University provides Celon Pharma with a strong pipeline of local, highly skilled engineering and scientific talent.
The custom-engineered facility is fully equipped for rigorous medical production, featuring a GMP-certified cleanroom and lab space, a sterilised water tank system integrated beneath the structure, and advanced temperature-controlled cold storage.
Certified clean rooms
Posizione strategica di confine
Educated workforce
Altre storie dei clienti
Iscriviti alla nostra newsletter
Ricevi nella tua casella di posta elettronica le ultime novità dal leader del mercato immobiliare industriale.
